French National Institute of Health and Medical Research:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:French National Institute of Health and Medical Research - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C12095
◆発行会社(調査会社):GlobalData
◆発行日:2018年12月
◆ページ数:30
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
French National Institute of Health and Medical Research (INSERM) is a biomedical research institute that conducts research in biology, medicine and public health. The institute offers research in the therapeutic areas of neurosciences, cognitive sciences, neurology, psychiatry, cancer, immunology, inflammation, genetics, cancer, infectiology and microbiology, physiopathology, public health, health technologies, metabolism, cell biology and immunology, among others. It provides services in the areas of human diseases and research findings to the medical community, and to both national and international partners. INSERM also conducts translational research and development services. It operates research units and research centers. INSERM is headquartered in Paris, France.

French National Institute of Health and Medical Research – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
French National Institute of Health and Medical Research, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
French National Institute of Health and Medical Research, Medical Equipment Deals By Type, 2012 to YTD 2018 6
French National Institute of Health and Medical Research, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
French National Institute of Health and Medical Research, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
French National Institute of Health and Medical Research, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
French National Institute of Health and Medical Research, Medical Equipment, Deal Details 11
Venture Financing 11
Eyevensys Secures Venture Funding 11
BioAxial Raises US$2.6 Million In Series A Financing 12
Partnerships 13
Advanced Biological Labs Enters into Licensing Agreement with Inserm Transfert 13
Advanced Biological Labs, Inserm Transfert and Centre Hospitalier Universitaire Enter into Licensing Agreement for PyroVir software 14
Tataa Biocenter Enters into Licensing Agreement with Inserm for ValidPrime Technology 15
IntegraGen Enters Into Licensing Agreement With Paris Descartes University For hsa-miR-31-3p 16
Qiagen Enters Into Licensing Agreement With Inserm Transfert For Colorectal Cancer Biomarker 18
Dassault Systemes Enters into Agreement with Inserm Transfert 19
Sebia Enters Into Co-Development Agreement With Institut National de la Sante And Inserm Transfert 20
Imcheck Therapeutics Enters Into Licensing Agreement with Inserm Transfert and SATT South East 21
Inserm Transfert Enters into Licensing Agreement with HalioDx 22
PEP-Therapy Enters into Agreement with Inserm Transfert, Institut Curie and Pierre and Marie 23
French National Institute of Health and Medical Research – Key Competitors 24
French National Institute of Health and Medical Research – Key Employees 25
French National Institute of Health and Medical Research – Locations And Subsidiaries 26
Head Office 26
Other Locations & Subsidiaries 26
Affiliate 26
Recent Developments 27
Government and Public Interest 27
Jun 01, 2018: Immunoscore: a test to improve the care and treatment of colon cancer 27
Product News 28
Aug 31, 2018: Implantable electronic device could stop epileptic seizures 28
Other Significant Developments 29
Aug 20, 2018: Bioengineered tooth replacement opens doors to new therapies 29
Appendix 30
Methodology 30
About GlobalData 30
Contact Us 30
Disclaimer 30

List of Tables
French National Institute of Health and Medical Research, Medical Equipment, Key Facts 2
French National Institute of Health and Medical Research, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
French National Institute of Health and Medical Research, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
French National Institute of Health and Medical Research, Medical Equipment Deals By Type, 2012 to YTD 2018 6
French National Institute of Health and Medical Research, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
French National Institute of Health and Medical Research, Deals By Market, 2012 to YTD 2018 8
French National Institute of Health and Medical Research, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Eyevensys Secures Venture Funding 11
BioAxial Raises US$2.6 Million In Series A Financing 12
Advanced Biological Labs Enters into Licensing Agreement with Inserm Transfert 13
Advanced Biological Labs, Inserm Transfert and Centre Hospitalier Universitaire Enter into Licensing Agreement for PyroVir software 14
Tataa Biocenter Enters into Licensing Agreement with Inserm for ValidPrime Technology 15
IntegraGen Enters Into Licensing Agreement With Paris Descartes University For hsa-miR-31-3p 16
Qiagen Enters Into Licensing Agreement With Inserm Transfert For Colorectal Cancer Biomarker 18
Dassault Systemes Enters into Agreement with Inserm Transfert 19
Sebia Enters Into Co-Development Agreement With Institut National de la Sante And Inserm Transfert 20
Imcheck Therapeutics Enters Into Licensing Agreement with Inserm Transfert and SATT South East 21
Inserm Transfert Enters into Licensing Agreement with HalioDx 22
PEP-Therapy Enters into Agreement with Inserm Transfert, Institut Curie and Pierre and Marie 23
French National Institute of Health and Medical Research, Key Competitors 24
French National Institute of Health and Medical Research, Key Employees 25
French National Institute of Health and Medical Research, Subsidiaries 26
French National Institute of Health and Medical Research, Affiliate 26

List of Figures
French National Institute of Health and Medical Research, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
French National Institute of Health and Medical Research, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
French National Institute of Health and Medical Research, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
French National Institute of Health and Medical Research, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
French National Institute of Health and Medical Research, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
French National Institute of Health and Medical Research, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
French National Institute of Health and Medical Research, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
French National Institute of Health and Medical Research, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[French National Institute of Health and Medical Research:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Daiwa Can Co., Ltd.:企業の戦略・SWOT・財務情報
    Daiwa Can Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Daiwa Can Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Republic Services Inc (RSG):企業の財務・戦略的SWOT分析
    Republic Services Inc (RSG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • McCormick & Company Incorporated:戦略・SWOT・企業財務分析
    McCormick & Company Incorporated - Strategy, SWOT and Corporate Finance Report Summary McCormick & Company Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Elong Inc:企業の戦略・SWOT・財務分析
    Elong Inc - Strategy, SWOT and Corporate Finance Report Summary Elong Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Chico’s FAS Inc:企業の戦略・SWOT・財務情報
    Chico's FAS Inc - Strategy, SWOT and Corporate Finance Report Summary Chico's FAS Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Terumo Corp (4543):医療機器:M&Aディール及び事業提携情報
    Summary Terumo Corp (Terumo) is a medical technology company, which manufactures and sells a wide range of medical care products including hospital and medical products, and equipment. Its major product categories include vascular interventional products, cardiovascular surgical systems, artificial …
  • C. R. Bard Inc (BCR)-医療機器分野:企業M&A・提携分析
    Summary C. R. Bard Inc (Bard) is a medical device company, which offers medical, surgical, diagnostic and patient care devices related to vascular disorders, urology disorders, cancer diagnosis and treatment and surgical specialties. Its major products include devices for the treatment of peripheral …
  • Teva Pharmaceutical Industries Ltd (TEVA):企業の財務・戦略的SWOT分析
    Teva Pharmaceutical Industries Ltd (TEVA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • Dimension Data Holdings Plc:企業の戦略的SWOT分析
    Dimension Data Holdings Plc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • TyraTech Inc (TYR):企業の財務・戦略的SWOT分析
    Summary TyraTech Inc (TyraTech) is a clean technology and life science company that manufactures, markets, and develops insect and parasite control products. The company offers products such as equine fly spray, head lice solutions, insect repellent, insect and parasite products, and production anim …
  • Armed Forces Insurance:企業の戦略的SWOT分析
    Armed Forces Insurance - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • E. Bon Holdings Limited (599):企業の財務・戦略的SWOT分析
    E. Bon Holdings Limited (599) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Daybreak Oil and Gas Inc (DBRM):企業の財務・戦略的SWOT分析
    Summary Daybreak Oil and Gas Inc (Daybreak) is an oil and gas company that explores and develops oil and natural gas assets. The company’s projects include East Slopes project and Michigan Basin project. Its East Slopes project is located in south-eastern art of the San Joaquin Basin, California. Da …
  • SolaCom Technologies, Inc.:企業の戦略・SWOT・財務情報
    SolaCom Technologies, Inc. - Strategy, SWOT and Corporate Finance Report Summary SolaCom Technologies, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Verrica Pharmaceuticals Inc (VRCA):製薬・医療:M&Aディール及び事業提携情報
    Summary Verrica Pharmaceuticals Inc (Verrica) is a clinical-stage medical dermatology company that discovers, develops and commercializes therapeutics for the treatment of skin diseases. The company’s lead product candidate, VP-102, is in two phase 3 clinical trials for the treatment of molluscum co …
  • GFT Technologies AG (GFT):企業の財務・戦略的SWOT分析
    Summary GFT Technologies AG (GFT Technologies) is a technology company that implements, develops, and maintains information technology solutions. The company’s services comprise application management, bespoke development, product based implementation, and business and IT consultation services. It a …
  • Aviakompaniya Sibir” OAO (P):企業の戦略・SWOT・財務情報
    Aviakompaniya Sibir'' OAO (P) - Strategy, SWOT and Corporate Finance Report Summary Aviakompaniya Sibir'' OAO (P) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Xylem Inc (XYL):企業の財務・戦略的SWOT分析
    Xylem Inc (XYL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Transfield Holdings Pty Ltd:企業の戦略的SWOT分析
    Transfield Holdings Pty Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Infratil Ltd (IFT):企業の財務・戦略的SWOT分析
    Infratil Ltd (IFT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆